StemCells (STEM) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Price: $3.59 --0%
EPS Growth %: +46.1%
Financial Fact:
Total revenue: 29.31K
Today's EPS Names:
NTRP, FMCB, LOOP, More
EPS Growth %: +46.1%
Financial Fact:
Total revenue: 29.31K
Today's EPS Names:
NTRP, FMCB, LOOP, More
Join SI Premium – FREE
StemCells (NASDAQ: STEM) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $28 thousand versus the consensus estimate of $30 thousand.
For earnings history and earnings-related data on StemCells (STEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FMC tumbles 35% after slashing Q3 outlook over weak demand and inventory issues
- Kimberly-Clark shares rise following preliminary Q3 earnings beat
- Bank7 Corp. (BSVN) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
